Healthcare provider profile · identity verified

Jennie B Hounshell, MD

Family Practice · WAUNAKEE, WI · NPI 1649249988

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	506	129
Amlodipine Besylate	Amlodipine Besylate	241	67
Lisinopril	Lisinopril	224	60
Omeprazole	Omeprazole	201	60
Levothyroxine Sodium	Levothyroxine Sodium	185	44
Rosuvastatin Calcium	Rosuvastatin Calcium	147	41
Metformin Hcl Er	Metformin Hcl	141	40
Eliquis	Apixaban	133	25
Losartan Potassium	Losartan Potassium	126	32
Jardiance	Empagliflozin	125	22
Duloxetine Hcl	Duloxetine Hcl	123	19
Hydrochlorothiazide	Hydrochlorothiazide	111	34
Gabapentin	Gabapentin	106	27
Metoprolol Succinate	Metoprolol Succinate	93	22
Furosemide	Furosemide	87	31
Sertraline Hcl	Sertraline Hcl	79	23
Tamsulosin Hcl	Tamsulosin Hcl	78	20
Albuterol Sulfate Hfa	Albuterol Sulfate	74	24
Pantoprazole Sodium	Pantoprazole Sodium	74	19
Trazodone Hcl	Trazodone Hcl	70	25
Famotidine	Famotidine	68	17
Allopurinol	Allopurinol	63	12
Oxycodone Hcl	Oxycodone Hcl	63	14
Escitalopram Oxalate	Escitalopram Oxalate	61	16
Mounjaro	Tirzepatide	61	suppressed
Simvastatin	Simvastatin	61	18
Alendronate Sodium	Alendronate Sodium	56	18
Metformin Hcl	Metformin Hcl	53	14
Metoprolol Tartrate	Metoprolol Tartrate	53	16
Spironolactone	Spironolactone	53	16
Trulicity	Dulaglutide	50	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	48	15
Mirtazapine	Mirtazapine	48	13
Prednisone	Prednisone	45	25
Potassium Chloride	Potassium Chloride	44	14
Clonazepam	Clonazepam	41	suppressed
Irbesartan	Irbesartan	41	12
Olmesartan Medoxomil	Olmesartan Medoxomil	40	12
Valsartan	Valsartan	39	12
Benazepril Hcl	Benazepril Hcl	38	suppressed
Tizanidine Hcl	Tizanidine Hcl	38	21
Bupropion Xl	Bupropion Hcl	37	12
Chlorthalidone	Chlorthalidone	37	suppressed
Atenolol	Atenolol	35	suppressed
Finasteride	Finasteride	35	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	35	suppressed
Methenamine Hippurate	Methenamine Hippurate	35	suppressed
Tramadol Hcl	Tramadol Hcl	35	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	34	suppressed
Fluticasone Propionate	Fluticasone Propionate	33	14
Citalopram Hbr	Citalopram Hydrobromide	30	suppressed
Ozempic	Semaglutide	30	suppressed
Pravastatin Sodium	Pravastatin Sodium	28	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	28	suppressed
Amoxicillin	Amoxicillin	27	15
Pregabalin	Pregabalin	27	suppressed
Xarelto	Rivaroxaban	27	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	26	suppressed
Morphine Sulfate Er	Morphine Sulfate	26	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	26	suppressed
Ropinirole Hcl	Ropinirole Hcl	26	suppressed
Synthroid	Levothyroxine Sodium	26	suppressed
Ezetimibe	Ezetimibe	25	suppressed
Valacyclovir	Valacyclovir Hcl	25	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	24	suppressed
Farxiga	Dapagliflozin Propanediol	23	suppressed
Diazepam	Diazepam	22	11
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Baclofen	Baclofen	20	suppressed
Buspirone Hcl	Buspirone Hcl	20	suppressed
Digoxin	Digoxin	20	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	20	17
Levetiracetam	Levetiracetam	18	suppressed
Novolog Flexpen	Insulin Aspart	18	suppressed
Amiodarone Hcl	Amiodarone Hcl	17	suppressed
Donepezil Hcl	Donepezil Hcl	17	suppressed
Estradiol	Estradiol	17	suppressed
Lovastatin	Lovastatin	17	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	17	suppressed
Myrbetriq	Mirabegron	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	17	suppressed
Verapamil Er	Verapamil Hcl	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Celecoxib	Celecoxib	15	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	11
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Loperamide	Loperamide Hcl	14	suppressed
Morphine Sulfate	Morphine Sulfate	14	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	14	suppressed
Bumetanide	Bumetanide	13	suppressed
Colchicine	Colchicine	13	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Lorazepam	Lorazepam	13	suppressed
Nystatin	Nystatin	13	suppressed
Zafirlukast	Zafirlukast	13	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	12	suppressed
Carvedilol	Carvedilol	12	suppressed
Creon	Lipase/Protease/Amylase	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Fenofibrate	Fenofibrate,micronized	12	suppressed
Ibandronate Sodium	Ibandronate Sodium	12	suppressed
Warfarin Sodium	Warfarin Sodium	12	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error